These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Unfractionated versus low-molecular-weight heparin for deep venous thrombosis. Penner J N Engl J Med; 1996 Aug; 335(9):671; author reply 671-2. PubMed ID: 8692247 [No Abstract] [Full Text] [Related]
3. Unfractionated versus low-molecular-weight heparin for deep venous thrombosis. Strandness DE N Engl J Med; 1996 Aug; 335(9):670-1; author reply 671-2. PubMed ID: 8692246 [No Abstract] [Full Text] [Related]
4. [Low-molecular-weight heparin in deep venous thrombosis. Dosage for all weight classes]. MMW Fortschr Med; 2003 Jun; 145(24):56. PubMed ID: 12866309 [No Abstract] [Full Text] [Related]
5. Improving use of heparin in acute deep venous thrombosis. Gold JA; Ferguson CJ; Williams NF; Braun SK Wis Med J; 1996 May; 95(5):311-2. PubMed ID: 8936037 [No Abstract] [Full Text] [Related]
6. [Monitoring blood coagulation]. Pabinger-Fasching I Wien Med Wochenschr; 1999; 149(2-4):70-1. PubMed ID: 10378328 [TBL] [Abstract][Full Text] [Related]
7. [Unfractionated standard heparin versus low molecular weight heparins]. Schrader J; Haas S Internist (Berl); 1993 Nov; 34(11):1053-7; discussion 1058. PubMed ID: 8282491 [No Abstract] [Full Text] [Related]
11. When can the patient with deep venous thrombosis begin to ambulate? Aldrich D; Hunt DP Phys Ther; 2004 Mar; 84(3):268-73. PubMed ID: 14984299 [No Abstract] [Full Text] [Related]
12. ["How must deep leg venous thrombosis be diagnosed and treated?"]. Bruhn HD Dtsch Med Wochenschr; 2003 Aug; 128(33):1730-1. PubMed ID: 12920673 [No Abstract] [Full Text] [Related]
13. Management of iliofemoral thrombosis in a pregnant patient with heparin resistance. Anand SS; Brimble S; Ginsberg JS Arch Intern Med; 1997 Apr; 157(7):815-6. PubMed ID: 9125015 [TBL] [Abstract][Full Text] [Related]
14. Practice tips. Deep venous thrombosis: before and after. Improving diagnosis and adjusting duration of therapy. Greiver M Can Fam Physician; 2000 Apr; 46():813-5. PubMed ID: 10790813 [No Abstract] [Full Text] [Related]
15. [Secondary prevention after leg and pelvic vein thrombosis with low molecular weight heparin]. Hamann H; Reuchlin G Vasa Suppl; 1992; 35():107-8. PubMed ID: 1336216 [No Abstract] [Full Text] [Related]
16. [Monitoring of heparin in the treatment of deep venous thrombosis. An obsolete question?]. Toulemonde F; Kher A Ann Cardiol Angeiol (Paris); 1995 Mar; 44(3):151-9. PubMed ID: 7793854 [TBL] [Abstract][Full Text] [Related]
17. Apparent heparin resistance form elevated factor VIII in a patient with postoperative deep venous thrombosis. A case report. Cirisano FD; Lee S; Greenspoon JS J Reprod Med; 1996 Mar; 41(3):191-4. PubMed ID: 8778420 [TBL] [Abstract][Full Text] [Related]
18. Low-molecular-weight heparin in patients with deep-vein thrombosis. Stricker H; Mombelli G N Engl J Med; 2001 Jul; 345(4):292-3. PubMed ID: 11474673 [No Abstract] [Full Text] [Related]
19. Effects of acute global venous obstruction and unfractionated heparin on muscle cytokine synthesis. Hua HT; Albadawi H; Entabi F; Conrad MF; Stoner MC; Houser S; Watkins MT Ann Vasc Surg; 2009; 23(1):108-15. PubMed ID: 18640815 [TBL] [Abstract][Full Text] [Related]
20. Should heparin be managed with a nomogram? Vine DL Kans Med; 1992 Dec; 93(12):359, 360. PubMed ID: 1287287 [No Abstract] [Full Text] [Related] [Next] [New Search]